Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

3.650

+0.310 (9.28%)

At close: Aug 19, 2026, 4:00 PM EDT

3.620

-0.030 (-0.82%)

Pre-market: Aug 20, 2026, 8:48 AM EDT

Rocket Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	401	380	1,312	2,702	1,481	1,407
Market Cap Growth	21.75%	-71.04%	-51.45%	82.43%	5.29%	-57.65%
Enterprise Value	142	182	1,102	2,290	1,197	1,008
Last Close Price	3.65	3.51	12.57	29.97	19.57	21.83
PB Ratio	1.08	1.37	2.83	5.49	3.03	3.09
P/TBV Ratio	1.32	1.78	3.29	6.31	3.49	3.32
Debt / Equity Ratio	0.07	0.09	0.06	0.05	0.05	0.05
Net Debt / Equity Ratio	-0.70	-0.59	-0.75	-0.71	-0.68	-0.80
Net Debt / EBITDA Ratio	1.42	0.75	1.32	1.40	1.53	2.28
Net Debt / FCF Ratio	1.52	0.86	1.61	1.65	1.79	2.84
Quick Ratio	9.06	6.26	9.15	7.69	9.10	17.54
Current Ratio	9.24	6.38	9.30	7.80	9.30	17.69
Return on Equity (ROE)	-4.77%	-60.27%	-54.14%	-50.01%	-46.98%	-35.29%
Return on Assets (ROA)	-28.42%	-33.29%	-31.21%	-28.69%	-26.68%	-19.10%
Return on Capital Employed (ROCE)	-49.00%	-76.10%	-56.10%	-49.60%	-43.70%	-35.00%
Earnings Yield	-4.31%	-58.74%	-19.73%	-9.09%	-14.98%	-12.02%
FCF Yield	-42.53%	-50.14%	-16.43%	-7.82%	-12.59%	-9.15%
Buyback Yield / Dilution	-8.61%	-17.21%	-12.85%	-23.27%	-7.77%	-14.18%

SEC Filings: 10-K · 10-Q